Article Text

Download PDFPDF
Microbial translocation in type 2 diabetes: when bacterial invaders overcome host defence in human obesity
  1. Benjamin AH Jensen1,2,
  2. Andre Marette1
  1. 1 Department of Medicine, Universite Laval Faculte de medecine, Quebec, Quebec, Canada
  2. 2 Center for Basic Metabolic Research, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark
  1. Correspondence to Dr Andre Marette, Laval University, Quebec, Canada; andre.marette{at}; Dr Benjamin AH Jensen; benjamin.jensen{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Metabolic endotoxemia, characterised by systemic influx of bacterial components, impairs lipid handling and glucoregulation.1 Early preclinical studies showed that high fat diet feeding facilitates bacterial translocation to metabolic tissues coinciding with dendritic cell (DC)-mediated inflammation.2 This process was aggravated in mice lacking either the canonical adaptor for inflammatory signalling pathways downstream of Toll-like receptor (TLR) families, MyD882 or the intracellular microbial pattern recognition receptor, NOD2.3 The first conceptual evidence for bacterial translocation in human type 2 diabetes (T2D) was reported in 2011 when Amar et al showed that 16S rDNA gene content in blood was associated with future T2D risk.4 These seminal papers pioneered the concept of bacterial translocation in metabolic diseases. Yet, it remains intensely debated whether bacterial translocation to extraintestinal tissues is a true phenomenon or a result of spurious data, as it is notoriously difficult to robustly distinguish biologically relevant bacterial DNA sequences in very low microbial biomass tissues from environmental contaminants.5 6 Indeed, low bacteria:host cell ratio obviously increases the risk of contamination during surgical procedures, biobanking and wet-laboratory processing of tissue samples. This has revivified the tenet that internal organs are sterile and casted doubt on emerging reports of tissue microbial signatures in a number of diseases, arguing that such findings may be confounded by sample contamination.

In GUT, Massier et al challenge again the dogma of sterile internal organs …

View Full Text


  • Twitter @TeamBenLab, @AndreMarette

  • BAJ and AM contributed equally.

  • Contributors BAHJ and AM contributed equally to the concept and writing of this manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles